Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
EVENTS PER QUARTER · HOVER FOR EMPLOYEE COUNTS
Baxter International Inc., a medical products maker, has announced plans for significant job cuts as it reduces its 2025 forecast, leading to a sharp decline in its stock price to a 19-year low. The company is facing challenges that have prompted this decision, although specific details regarding the number of positions to be eliminated and the timeline for these layoffs have not been disclosed. The announcement reflects ongoing struggles within the company and the broader market conditions affecting its operations.
Baxter Health has implemented a cost reduction plan that resulted in the elimination of 17 jobs. This decision is part of a broader strategy aimed at saving $10 million. The layoffs reflect the company's efforts to streamline operations and manage expenses effectively. While specific details about the affected locations or departments were not provided, the move underscores the challenges Baxter Health is facing in the current economic environment.
Baxter International Inc. has laid off 3% of its workforce at a plant impacted by Hurricane Helene. The layoffs are part of the company's response to the challenges posed by the hurricane, which affected operations. While the exact number of employees affected is not specified, the percentage indicates a significant reduction in staff at the facility. This decision reflects the ongoing adjustments Baxter is making in light of operational disruptions caused by the natural disaster.
Baxter International Inc. has laid off 90 employees from its facility in Marion, North Carolina. This decision has caused significant concern among the workforce, with employees expressing shock and disappointment. The layoffs are part of a broader restructuring effort within the company, which has been facing challenges in the current market. The affected employees were notified of their termination on October 1, 2023. Baxter's management has not provided specific details on the reasons behind the layoffs, but the company is reportedly adjusting its operations to better align with market demands.
Baxter International Inc. has announced layoffs affecting approximately 200 employees at its Guayama facility. The layoffs are part of a restructuring effort aimed at improving operational efficiency and adapting to changing market conditions. This decision comes as the company faces challenges in maintaining its competitive edge in the healthcare sector. The affected employees were notified on October 1, 2023, and the company is committed to providing support during this transition. Baxter's management emphasized the need for these cuts to ensure long-term sustainability and growth.
Baxter International Inc. has laid off approximately 300 employees at its manufacturing plant in Guayama, Puerto Rico. The layoffs were part of a restructuring effort, which has prompted the local government to activate aid measures to support the affected workers. The company has faced challenges in maintaining operations, leading to these workforce reductions. The government is now working to provide assistance to those impacted by the job cuts, highlighting the community's commitment to supporting displaced workers during this transition.
No one has shared a story from Baxter International Inc. yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →We'll email you the moment a new layoff is reported here.